Julio Bunay

7PUBLICATIONS
18CO-AUTHORS
Haematological tumoursBiologically active moleculesPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 31, 2026
The Phospholipid Bis(monoacylglycero)Phosphate Confers Antitumour Immunogenicity to Exosomes Secreted by Dendrogenin A, Which Activates Its Biosynthesis in Tumour Cells.

Julio Buñay, Michel Record, Philippe de Medina

|Jun 10, 2023
Chemical Composition of Essential Oil of Cymbopogon schoenanthus (L.) Spreng from Burkina Faso, and Effects against Prostate and Cervical Cancer Cell Lines.

Bagora Bayala, Laetizia Liz Coulibaly, Florencia Djigma

|Sep 05, 2022
Targeting NR1H/liver X receptor with dendrogenin A differentiates tumor cells to activate a new secretory pathway releasing immunogenic anti-tumor vesicles enriched in LC3-II-associated exosomes.

Philippe de Medina, Julio Bunay, Marc Poirot

|Apr 12, 2022
Targeting the liver X receptor with dendrogenin A differentiates tumour cells to secrete immunogenic exosome-enriched vesicles.

Michel Record, Mehdi Attia, Kevin Carayon

|Dec 07, 2020
Absence of nuclear receptors LXRs impairs immune response to androgen deprivation and leads to prostate neoplasia.

Laura Bousset, Amandine Septier, Julio Bunay

|Oct 20, 2020
Screening for liver X receptor modulators: Where are we and for what use?

Julio Buñay, Allan Fouache, Amalia Trousson

Pageof 2

Frequent Collaborators

4 joint publications

Jean-Marc A Lobaccaro

3 joint publications

Philippe de Medina

3 joint publications

Sandrine Silvente-Poirot

3 joint publications

Marc Poirot